Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation
- PMID: 18217903
- DOI: 10.1111/j.1399-0012.2007.00738.x
Single time point measurement by C2 or C3 is highly predictive in cyclosporine area under the curve estimation immediately after lung transplantation
Abstract
Background: The two h post-dose cyclosporine (CsA) concentration has been advocated as the optimal time point measurement for CsA area under the curve (AUC) estimation after solid organ transplantation. The aim of the study was to investigate whether intensified CsA monitoring is necessary, or if a single time point measurement is accurate to estimate the AUC in the very early period following lung transplantation (LuTX).
Methods: Within the first two wk following transplantation, daily AUCs were calculated by serial CsA measurements at zero, one, two, three, four, and six h (C0-C6) in 12 consecutive lung transplant recipients. Correlation of single CsA measurements and AUC as well as linear regression analysis was performed to evaluate the most predictive single CsA blood level regarding the AUC.
Results: A total of 606 CsA concentration measurements were performed and the 101 corresponding AUCs were calculated for each patient. Mean AUC was 3443 +/- 1451 microg/L. C0: 361 +/- 118 microg/L, C1: 481 +/- 231 microg/L, C2: 682 +/- 314 microg/L, C3: 715 +/- 347 microg/L, C4: 658 +/- 271 microg/L, C6: 571 +/- 260 microg/L. The correlation of CsA serum levels with AUC was the lowest at trough levels (C0) with a correlation coefficient (r = 0.31) and highest at three h (C3: r = 0.89) and two h (C2: r = 0.88).
Conclusions: Similar to a stable post-transplant period, CsA trough levels turned out to have poor correlation with the corresponding AUC early after LuTX. The highest correlation of C3 with the AUC may be explained by delayed intestinal resorption immediately post-operative, however C2 is a peer parameter. Optimum AUCs and corresponding C2 or C3 levels in the immediate post-operative phase however remain to be determined.
Similar articles
-
Monitoring C2 level predicts exposure in maintenance lung transplant patients receiving the microemulsion formulation of cyclosporine (Neoral).J Heart Lung Transplant. 2005 Aug;24(8):1076-80. doi: 10.1016/j.healun.2003.05.002. J Heart Lung Transplant. 2005. PMID: 16102443
-
Association between cyclosporine concentrations at 2 hours post-dose and clinical outcomes in de novo lung transplant recipients.J Heart Lung Transplant. 2005 Dec;24(12):2120-8. doi: 10.1016/j.healun.2005.05.005. Epub 2005 Oct 3. J Heart Lung Transplant. 2005. PMID: 16364860 Clinical Trial.
-
A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.Clin Ther. 2006 Jun;28(6):893-905. doi: 10.1016/j.clinthera.2006.06.015. Clin Ther. 2006. PMID: 16860172
-
Is C2 monitoring or another limited sampling strategy superior to C0 monitoring in improving clinical outcomes in adult liver transplant recipients?Ther Drug Monit. 2006 Oct;28(5):637-42. doi: 10.1097/01.ftd.0000243965.97964.ca. Ther Drug Monit. 2006. PMID: 17038878 Review.
-
History of C2 monitoring in heart and liver transplant patients treated with cyclosporine microemulsion.Transplant Proc. 2004 Mar;36(2 Suppl):442S-447S. doi: 10.1016/j.transproceed.2004.01.004. Transplant Proc. 2004. PMID: 15041383 Review.
Cited by
-
Screening gene signatures for clinical response subtypes of lung transplantation.Mol Genet Genomics. 2022 Sep;297(5):1301-1313. doi: 10.1007/s00438-022-01918-x. Epub 2022 Jul 3. Mol Genet Genomics. 2022. PMID: 35780439
-
Ciclosporin population pharmacokinetics and Bayesian estimation in thoracic transplant recipients.Clin Pharmacokinet. 2013 Apr;52(4):277-88. doi: 10.1007/s40262-013-0037-x. Clin Pharmacokinet. 2013. PMID: 23400901 Clinical Trial.
-
Pharmacokinetic optimization of immunosuppressive therapy in thoracic transplantation: part I.Clin Pharmacokinet. 2009;48(7):419-62. doi: 10.2165/11317230-000000000-00000. Clin Pharmacokinet. 2009. PMID: 19691367 Free PMC article. Review.
-
Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica.J Neurol. 2013 Feb;260(2):627-34. doi: 10.1007/s00415-012-6692-2. Epub 2012 Oct 18. J Neurol. 2013. PMID: 23076828
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous